Trials / Completed
CompletedNCT02630680
Eziclen Drug Utilisation in Real Life Setting
A Multicentre, European, Observational, Drug Utilisation Study (DUS) of BLI800 (Eziclen®/Izinova®) as a Bowel Cleansing Preparation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,286 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess Eziclen/Izinova drug utilisation in the real life setting in a representative sample of the European target population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eziclen®/Izinova® |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-04-25
- Completion
- 2017-04-25
- First posted
- 2015-12-15
- Last updated
- 2019-01-07
Locations
16 sites across 4 countries: Czechia, Germany, Netherlands, Poland
Source: ClinicalTrials.gov record NCT02630680. Inclusion in this directory is not an endorsement.